Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

Prenetics (NASDAQ: PRE) announced that IM8 Health has partnered with Vitamin Angels to address global malnutrition, committing to impact 400,000 pregnant women, infants, and children under five in year one.

Rhea-AI Summary

Prenetics (NASDAQ: PRE) announced that IM8 Health has partnered with Vitamin Angels to address global malnutrition, committing to impact 400,000 pregnant women, infants, and children under five in year one. Vitamin Angels reaches over 74 million people annually and holds a four-star Charity Navigator rating.

The partnership leverages IM8’s presence in 31 countries and Vitamin Angels’ 31-year delivery network, with a long-term ambition to scale to millions of lives through sustained funding and awareness.

Argus Apr 14 session

-0.88% close to close Open Argus

Details

News Market Reaction – PRE

On Apr 14, the day this news came out, PRE closed 0.88% below the previous close.

Data tracked by StockTitan Argus for the Apr 14 session.

Market Context

This announcement expands IM8’s strategy from premium nutrition to large-scale social impact, target...

Analysis

This announcement expands IM8’s strategy from premium nutrition to large-scale social impact, targeting 400,000 mothers and children in year one through Vitamin Angels, which already reaches 74 million people annually in 65+ countries. The deal complements a series of brand and technology partnerships highlighted in past releases. Investors may watch how IM8’s growing global footprint, partnership-driven model, and existing F-3 resale registration interact with future financial updates and execution milestones.

Key Figures

Year-one impact target: 400,000 mothers and children Underserved population: 3 billion people Annual reach: 74 million women and children +5 more

Year-one impact target

400,000 mothers and children

IM8 commitment with Vitamin Angels in first year

Underserved population

3 billion people

Global population unable to afford a healthy diet

Annual reach

74 million women and children

Vitamin Angels’ yearly reach across supported programs

Countries covered

65+ countries

Vitamin Angels’ global delivery footprint

Three-year program reach

220 million women and children

Vitamin Angels’ most recent three-year cycle

Lives saved

147,000 children

Estimated children’s lives saved over recent three-year cycle

Improved birth outcomes

209,000 births

Improved outcomes from Vitamin Angels’ interventions

IM8 country footprint

31 countries

IM8 clinical-grade nutrition customer reach

Previous Partnership Reports

4 past events · Latest: Apr 02

Same Type 4 events

1. Apr 02

   Celebrity partnership

   24h Move

   +0.6%

   Giannis Antetokounmpo becomes IM8 Global Partner and shareholder in multi-year deal.

2. Mar 24

   Diagnostics partnership

   24h Move

   +3.2%

   IM8 partners with Superpower to integrate clinical supplements with blood diagnostics.

3. Feb 11

   Web3 partnership

   24h Move

   -2.1%

   Genomics-based partnership with Humanity Protocol and launch of crypto strategic reserve.

4. Jul 11

   Celebrity partnership

   24h Move

   +12.7%

   David Beckham partners with Prenetics and co-founds IM8 consumer health brand.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

clinical-grade nutrition, prenatal vitamins, deworming treatments, stunting, +1 more

5 terms

clinical-grade nutrition medical

"IM8 was created to make clinical-grade nutrition accessible to health-conscious consumers worldwide"

Clinical-grade nutrition are medically formulated food products made to meet strict safety, purity and performance standards for use in hospitals or under a doctor’s supervision. Think of them like a prescription version of dietary supplements: they are tested and produced to specific specifications so clinicians can rely on predictable results for patient care, making them important to investors because they face higher regulatory barriers, stable demand, and clearer reimbursement pathways than consumer products.

prenatal vitamins medical

"Vitamin Angels’ evidence-based nutrition solutions — including prenatal vitamins and minerals, vitamin A supplementation"

Prenatal vitamins are specially formulated dietary supplements designed to provide key nutrients—like folic acid, iron, calcium and certain vitamins—that support a woman’s health and fetal development during pregnancy. Investors care because they are a repeat-purchase consumer healthcare product with demand tied to birth rates, public health guidelines and insurance or retail coverage; changes in regulation, supply or demographic trends can directly affect sales, margins and brand value.

deworming treatments medical

"vitamin A supplementation, and deworming treatments — have been proven to save children’s lives"

Deworming treatments are medicines or products designed to remove or kill parasitic worms that infect humans or animals, restoring health and preventing further spread. For investors, they matter because demand, regulatory approvals, dosing schedules and large-scale public health or livestock programs can drive steady sales, influence pricing and affect a company’s revenue and risk profile—similar to how a regular maintenance plan protects a fleet of vehicles from breakdowns.

stunting medical

"have been proven to save children’s lives, improve birth outcomes, and reduce stunting"

Chronic undernutrition in early childhood that prevents children from reaching their expected height and developmental milestones, often measured as low height-for-age. It also signals lasting effects on brain development, learning ability and immune strength. Investors care because stunting predicts lower future workforce productivity, higher health costs and sustained demand for nutrition and healthcare solutions in affected regions—similar to a factory whose machinery was never fully built and therefore produces less over its lifetime.

Charity Navigator rating technical

"Vitamin Angels Reaches Over 74 Million Women and Children Annually ... with a four-star Charity Navigator Rating"

A Charity Navigator rating is an independent score that evaluates a nonprofit’s financial health, accountability, and transparency, much like a credit score tells you how reliably someone manages money. Investors and companies use the rating to assess the quality and trustworthiness of charitable partners and to gauge reputational and social-impact risks tied to corporate giving, making it a practical tool for charitable due diligence and ESG-related decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Partnership Extends IM8’s Mission Beyond Premium Nutrition to Address Malnutrition Among the World’s Most Vulnerable Populations

Long-Term Goal to Impact Millions of Lives Through Sustained Funding and Awareness

Vitamin Angels Reaches Over 74 Million Women and Children Annually Across 65+ Countries with a four-star Charity Navigator Rating

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), the parent company of IM8, the premium health and longevity brand co-founded with David Beckham, today announced a global partnership with Vitamin Angels, a leading global health nonprofit dedicated to improving nutrition outcomes for underserved pregnant women, infants, and young children worldwide.

Under the partnership, IM8 has committed to impacting 400,000 pregnant women, infants, and children under five in underserved communities during its first year. The Company’s long-term ambition is to scale this commitment to reach millions of lives in the years ahead, leveraging IM8’s growing global footprint and Vitamin Angels’ proven delivery infrastructure across more than 65 countries.

The partnership represents a natural extension of IM8’s founding mission. While IM8 was created to make clinical-grade nutrition accessible to health-conscious consumers worldwide, the Company recognizes that nearly three billion people globally cannot afford a healthy diet, and that malnutrition during pregnancy and early childhood remains one of the most significant barriers to human potential. By partnering with Vitamin Angels — an organization with a 31-year track record, a four-star Charity Navigator rating, and the infrastructure to reach over 74 million women and children annually — IM8 is extending its mission from premium nutrition to universal impact.

Vitamin Angels’ evidence-based nutrition solutions — including prenatal vitamins and minerals, vitamin A supplementation, and deworming treatments — have been proven to save children’s lives, improve birth outcomes, and reduce stunting. During its most recent three-year strategic cycle, Vitamin Angels reached 220 million women and children, resulting in an estimated 147,000 children’s lives saved and over 209,000 improved birth outcomes.

“At IM8, we believe that access to quality nutrition is a fundamental right, not a privilege. We’ve built a brand that delivers clinical-grade nutrition to consumers in 31 countries — but our responsibility doesn’t stop with our customers. Partnering with Vitamin Angels allows us to direct our expertise and resources toward the communities that need it most: mothers and children who don’t have access to even basic nutrition. Our commitment to impacting 400,000 lives in year one is just the beginning — our goal is to reach millions,” said Danny Yeung, Co-Founder and CEO of Prenetics and IM8 Health.

“We are proud to welcome IM8 Health as a Vitamin Angels partner. This partnership reflects a strong, shared commitment to making essential nutrition accessible to those who need it most,” said Ana Céspedes, CEO of Vitamin Angels. “In its first year alone, IM8’s support will help reach 400,000 women and children —an incredible step toward creating healthier futures. By embedding purpose into its core, IM8 is helping drive sustainable, lasting change in global health. We look forward to the impact we will achieve together.”

About Prenetics Global Limited

Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company’s flagship consumer brand, IM8, co-founded with David Beckham and trusted by NBA superstar, Giannis Antetokounmpo, World No. 1 tennis player Aryna Sabalenka and F1 phenom Ollie Bearman, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing $100 million in annualized recurring revenue within just 11 months of operations, and is now sold in more than 30 countries worldwide.

About Vitamin Angels

Founded in 1994, Vitamin Angels is a global health nonprofit working to improve nutrition and health outcomes in low-resource settings worldwide. The organization strengthens, extends, and amplifies the impact of partner organizations working to reach the most nutritionally vulnerable groups — pregnant women, infants, and young children — who are underserved by existing systems. Vitamin Angels works with over 800 local organizations, including governments, across more than 65 countries to reach over 74 million women and children annually with evidence-based nutrition interventions. Both Charity Navigator and Candid give Vitamin Angels their highest marks for financial transparency. To learn more, visit www.vitaminangels.org.

Investor Relations Contact:

investors@prenetics.com
PRE@mzgroup.us

Angela Cheung
Investor Relations / Corporate Finance
angela.hm.cheung@prenetics.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What exactly did Prenetics (PRE) announce on April 14, 2026 about IM8 Health and Vitamin Angels?

They announced a global partnership where IM8 will support Vitamin Angels to fight malnutrition. According to Prenetics, IM8 commits to impacting 400,000 mothers and children in the first year and aims to scale to millions using Vitamin Angels’ delivery network.

How many people does IM8 Health expect to reach in year one through the PRE partnership with Vitamin Angels?

IM8 expects to impact 400,000 pregnant women, infants, and children under five in the first year. According to Prenetics, the initiative leverages Vitamin Angels’ infrastructure across more than 65 countries to distribute nutrition interventions.

What is Vitamin Angels’ track record cited in the PRE announcement on April 14, 2026?

Vitamin Angels has a 31-year track record and a four-star Charity Navigator rating. According to Prenetics, Vitamin Angels reaches over 74 million women and children annually and reported large-scale impact in its recent strategic cycle.

How does the IM8 and Vitamin Angels partnership affect IM8’s global footprint (PRE)?

The partnership extends IM8’s mission from premium consumers to underserved communities. According to Prenetics, IM8 already distributes clinical-grade nutrition in 31 countries and will use Vitamin Angels to expand impact-focused distribution.

What nutrition interventions will IM8 Health support through the PRE partnership with Vitamin Angels?

The program will support evidence-based interventions like prenatal vitamins, vitamin A supplementation, and deworming treatments. According to Prenetics, these interventions are linked to improved birth outcomes and reduced child mortality and stunting.